Synthetic Δ-9-tetrahydrocannabinol (dronabinol) can improve the symptoms of schizophrenia / Glenn Schwarcz en Journal of Clinical Psychopharmacology, Año 2009 - Vol. 29 - No. 3 (Junio)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2009 - Vol. 29 - No. 3 (Junio) . - pp. 255-258 Título : Synthetic Δ-9-tetrahydrocannabinol (dronabinol) can improve the symptoms of schizophrenia Tipo de documento: texto impreso Autores: Glenn Schwarcz, Autor ; Basawaraj Karajgi, Autor ; Richard McCarthy, Autor Fecha de publicación: 2022 Artículo en la página: pp. 255-258 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Hipótesis cannabinoide de la esquizofrenia, Estimulación endocannabinoide Resumen: We are reporting improvement of symptoms of schizophrenia in a small group of patients who received the cannabinoid agonist dronabinol (synthetic Δ-9-tetrahydrocannabinol). Before this report, cannabinoids had usually been associated with worsening of psychotic symptoms. Link: ./index.php?lvl=notice_display&id=29506 [artículo] Synthetic Δ-9-tetrahydrocannabinol (dronabinol) can improve the symptoms of schizophrenia [texto impreso] / Glenn Schwarcz, Autor ; Basawaraj Karajgi, Autor ; Richard McCarthy, Autor . - 2022 . - pp. 255-258. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2009 - Vol. 29 - No. 3 (Junio) . - pp. 255-258 Palabras clave: Hipótesis cannabinoide de la esquizofrenia, Estimulación endocannabinoide Resumen: We are reporting improvement of symptoms of schizophrenia in a small group of patients who received the cannabinoid agonist dronabinol (synthetic Δ-9-tetrahydrocannabinol). Before this report, cannabinoids had usually been associated with worsening of psychotic symptoms. Link: ./index.php?lvl=notice_display&id=29506

---

1 (1 - 1 / 1)